Size-based enrichment technologies for CTC detection and characterization

Anthony Williams, Marija Balic, Ram Datar, Richard J Cote

Research output: Chapter in Book/Report/Conference proceedingChapter

22 Citations (Scopus)

Abstract

The degree of metastatic outspread in malignant disease is one of the leading factors in determining the appropriate course treatment. Circulating tumor cells (CTCs) represent the population of cells that have acquired the means to gain access to the circulatory system, and the cell population ultimately responsible for the development of metastases at distant sites in the body. While promising as a biomarker for metastatic disease, the widespread study of CTCs has been limited by their rarity, as CTCs are reported to occur as infrequently as 1/mL of whole blood. In this text, we will discuss current and emerging technologies for the size-based enrichment of CTCs from whole blood, and compare some of the advantages and disadvantages of using a size-based approach to CTC enrichment versus affinity-based CTC enrichment platforms.

Original languageEnglish
Title of host publicationRecent Results in Cancer Research
Pages87-95
Number of pages9
Volume195
DOIs
StatePublished - May 9 2012

Publication series

NameRecent Results in Cancer Research
Volume195
ISSN (Print)00800015

Fingerprint

Circulating Neoplastic Cells
Technology
Cardiovascular System
Population
Biomarkers
Neoplasm Metastasis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Williams, A., Balic, M., Datar, R., & Cote, R. J. (2012). Size-based enrichment technologies for CTC detection and characterization. In Recent Results in Cancer Research (Vol. 195, pp. 87-95). (Recent Results in Cancer Research; Vol. 195). https://doi.org/10.1007/978-3-642-28160-0_8

Size-based enrichment technologies for CTC detection and characterization. / Williams, Anthony; Balic, Marija; Datar, Ram; Cote, Richard J.

Recent Results in Cancer Research. Vol. 195 2012. p. 87-95 (Recent Results in Cancer Research; Vol. 195).

Research output: Chapter in Book/Report/Conference proceedingChapter

Williams, A, Balic, M, Datar, R & Cote, RJ 2012, Size-based enrichment technologies for CTC detection and characterization. in Recent Results in Cancer Research. vol. 195, Recent Results in Cancer Research, vol. 195, pp. 87-95. https://doi.org/10.1007/978-3-642-28160-0_8
Williams A, Balic M, Datar R, Cote RJ. Size-based enrichment technologies for CTC detection and characterization. In Recent Results in Cancer Research. Vol. 195. 2012. p. 87-95. (Recent Results in Cancer Research). https://doi.org/10.1007/978-3-642-28160-0_8
Williams, Anthony ; Balic, Marija ; Datar, Ram ; Cote, Richard J. / Size-based enrichment technologies for CTC detection and characterization. Recent Results in Cancer Research. Vol. 195 2012. pp. 87-95 (Recent Results in Cancer Research).
@inbook{0461a92518bb499b97b1c5dc06af24fa,
title = "Size-based enrichment technologies for CTC detection and characterization",
abstract = "The degree of metastatic outspread in malignant disease is one of the leading factors in determining the appropriate course treatment. Circulating tumor cells (CTCs) represent the population of cells that have acquired the means to gain access to the circulatory system, and the cell population ultimately responsible for the development of metastases at distant sites in the body. While promising as a biomarker for metastatic disease, the widespread study of CTCs has been limited by their rarity, as CTCs are reported to occur as infrequently as 1/mL of whole blood. In this text, we will discuss current and emerging technologies for the size-based enrichment of CTCs from whole blood, and compare some of the advantages and disadvantages of using a size-based approach to CTC enrichment versus affinity-based CTC enrichment platforms.",
author = "Anthony Williams and Marija Balic and Ram Datar and Cote, {Richard J}",
year = "2012",
month = "5",
day = "9",
doi = "10.1007/978-3-642-28160-0_8",
language = "English",
isbn = "9783642281594",
volume = "195",
series = "Recent Results in Cancer Research",
pages = "87--95",
booktitle = "Recent Results in Cancer Research",

}

TY - CHAP

T1 - Size-based enrichment technologies for CTC detection and characterization

AU - Williams, Anthony

AU - Balic, Marija

AU - Datar, Ram

AU - Cote, Richard J

PY - 2012/5/9

Y1 - 2012/5/9

N2 - The degree of metastatic outspread in malignant disease is one of the leading factors in determining the appropriate course treatment. Circulating tumor cells (CTCs) represent the population of cells that have acquired the means to gain access to the circulatory system, and the cell population ultimately responsible for the development of metastases at distant sites in the body. While promising as a biomarker for metastatic disease, the widespread study of CTCs has been limited by their rarity, as CTCs are reported to occur as infrequently as 1/mL of whole blood. In this text, we will discuss current and emerging technologies for the size-based enrichment of CTCs from whole blood, and compare some of the advantages and disadvantages of using a size-based approach to CTC enrichment versus affinity-based CTC enrichment platforms.

AB - The degree of metastatic outspread in malignant disease is one of the leading factors in determining the appropriate course treatment. Circulating tumor cells (CTCs) represent the population of cells that have acquired the means to gain access to the circulatory system, and the cell population ultimately responsible for the development of metastases at distant sites in the body. While promising as a biomarker for metastatic disease, the widespread study of CTCs has been limited by their rarity, as CTCs are reported to occur as infrequently as 1/mL of whole blood. In this text, we will discuss current and emerging technologies for the size-based enrichment of CTCs from whole blood, and compare some of the advantages and disadvantages of using a size-based approach to CTC enrichment versus affinity-based CTC enrichment platforms.

UR - http://www.scopus.com/inward/record.url?scp=84860593833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860593833&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-28160-0_8

DO - 10.1007/978-3-642-28160-0_8

M3 - Chapter

SN - 9783642281594

VL - 195

T3 - Recent Results in Cancer Research

SP - 87

EP - 95

BT - Recent Results in Cancer Research

ER -